Literature DB >> 20011645

Recommendations for the use of antithrombin concentrates and prothrombin complex concentrates.

Giancarlo Liumbruno1, Francesco Bennardello, Angela Lattanzio, Pierluigi Piccoli, Gina Rossetti.   

Abstract

Mesh：

Substances：

Year:  2009        PMID： 20011645      PMCID： PMC2782811          DOI： 10.2450/2009.0116-09

Source DB:  PubMed          Journal:  Blood Transfus        ISSN： 1723-2007            Impact factor:   3.443


× No keyword cloud information.
  64 in total

1.  A comparison of the efficacy and rate of response to oral and intravenous Vitamin K in reversal of over-anticoagulation with warfarin.

Authors:  H G Watson; T Baglin; S L Laidlaw; M Makris; F E Preston
Journal:  Br J Haematol       Date:  2001-10       Impact factor: 6.998

2.  Antithrombin supplementation III in childhood acute lymphoblastic leukemia treated with L-asparaginase.

Authors:  Akinobu Matsuzaki; Aiko Suminoe; Toshiro Hara
Journal:  Pediatr Hematol Oncol       Date:  2002-12       Impact factor: 1.969

3.  Beriplex P/N reverses severe warfarin-induced overanticoagulation immediately and completely in patients presenting with major bleeding.

Authors:  G Evans; R Luddington; T Baglin
Journal:  Br J Haematol       Date:  2001-12       Impact factor: 6.998

4.  Rapid reversal of oral anticoagulation with warfarin by a prothrombin complex concentrate (Beriplex): efficacy and safety in 42 patients.

Authors:  F E Preston; S T Laidlaw; B Sampson; S Kitchen
Journal:  Br J Haematol       Date:  2002-03       Impact factor: 6.998

5.  Hemostatic problems and thromboembolic complications in nephrotic children.

Authors:  A Citak; S Emre; A Sâirin; I Bilge; A Nayir
Journal:  Pediatr Nephrol       Date:  2000-02       Impact factor: 3.714

6.  Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial.

Authors:  B L Warren; A Eid; P Singer; S S Pillay; P Carl; I Novak; P Chalupa; A Atherstone; I Pénzes; A Kübler; S Knaub; H O Keinecke; H Heinrichs; F Schindel; M Juers; R C Bone; S M Opal
Journal:  JAMA       Date:  2001-10-17       Impact factor: 56.272

7.  Prothrombin complex concentrate (Octaplex) in patients requiring immediate reversal of oral anticoagulation.

Authors:  Hanno B Riess; Andreas Meier-Hellmann; Johann Motsch; Mazen Elias; Friedrich W Kursten; Carl-Erik Dempfle
Journal:  Thromb Res       Date:  2007-04-03       Impact factor: 3.944

Review 8.  Clinical trial results with antithrombin III in sepsis.

Authors:  F Fourrier; M Jourdain; A Tournoys
Journal:  Crit Care Med       Date:  2000-09       Impact factor: 7.598

9.  The role of antithrombin III in critical patients in obstetrics.

Authors:  S Mangione; A Giarratano
Journal:  Minerva Anestesiol       Date:  2002-05       Impact factor: 3.051

10.  Antithrombin III in patients admitted to intensive care units: a multicenter observational study.

Authors:  Andrea Messori; Franca Vacca; Monica Vaiani; Sabrina Trippoli
Journal:  Crit Care       Date:  2002-07-24       Impact factor: 9.097
View more
  13 in total

Review 1.  Prothrombin complex concentrates: an update.

Authors:  Massimo Franchini; Giuseppe Lippi
Journal:  Blood Transfus       Date:  2010-07       Impact factor: 3.443

Review 2.  Clinical use and the Italian demand for antithrombin.

Authors:  Giancarlo M Liumbruno; Massimo Franchini; Monica Lanzoni; Fabio Candura; Stefania Vaglio; Samantha Profili; Liviana Catalano; Giuseppina Facco; Simonetta Pupella; Gabriele Calizzani; Giuliano Grazzini
Journal:  Blood Transfus       Date:  2013-09       Impact factor: 3.443

Review 3.  Clinical use and the Italian demand for prothrombin complex concentrates.

Authors:  Massimo Franchini; Giancarlo M Liumbruno; Monica Lanzoni; Fabio Candura; Stefania Vaglio; Samantha Profili; Giuseppina Facco; Gabriele Calizzani; Giuliano Grazzini
Journal:  Blood Transfus       Date:  2013-09       Impact factor: 3.443

4.  The clinical use of albumin: a topic for Transfusion Medicine.

Authors:  Claudio Velati
Journal:  Blood Transfus       Date:  2009-10       Impact factor: 3.443

5.  Recommendations for the transfusion management of patients in the peri-operative period. II. The intra-operative period.

Authors:  Giancarlo Maria Liumbruno; Francesco Bennardello; Angela Lattanzio; Pierluigi Piccoli; Gina Rossetti
Journal:  Blood Transfus       Date:  2011-04       Impact factor: 3.443

6.  Recommendations for the transfusion management of patients in the peri-operative period. I. The pre-operative period.

Authors:  Giancarlo Maria Liumbruno; Francesco Bennardello; Angela Lattanzio; Pierluigi Piccoli; Gina Rossetti
Journal:  Blood Transfus       Date:  2011-01       Impact factor: 3.443

7.  Transfusion therapy in the peri-operative period.

Authors:  Giuseppe Aprili; Claudio Velati; Giancarlo Maria Liumbruno
Journal:  Blood Transfus       Date:  2011-01       Impact factor: 3.443

Review 8.  How we treat bleeding associated with direct oral anticoagulants.

Authors:  Giuseppe Marano; Stefania Vaglio; Simonetta Pupella; Giancarlo M Liumbruno; Massimo Franchini
Journal:  Blood Transfus       Date:  2016-01-19       Impact factor: 3.443

Review 9.  Inherited risk factors for venous thromboembolism.

Authors:  Ida Martinelli; Valerio De Stefano; Pier M Mannucci
Journal:  Nat Rev Cardiol       Date:  2014-01-14       Impact factor: 32.419

Review 10.  Perioperative management of the bleeding patient.

Authors:  K Ghadimi; J H Levy; I J Welsby
Journal:  Br J Anaesth       Date:  2016-12       Impact factor: 9.166
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.